Human lymphoblastoid cell line and hybridomas derived therefrom
US4897466A · kind A · utility
0Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 1986 |
| Grant date | Jan 30, 1990 |
| Priority date | — |
| Expiry date | Jun 6, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/809
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A 6-thioguanine-resistant subvariant of the EBV-transformed human lymphoblastoid B cell line WI-L2 is described. The subvariant line, designated LTR228, fuses efficiently with human cells. Human.times.human hybridomas derived from LTR228 that produce monoclonal antibodies against tetanus toxin and blood group A are exemplified.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.